Aptose Biosciences to Participate in Cantor's The Future of Oncology Virtual Symposium

Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, today announced that the company will be participating in Cantor Fitzgerald's The Future of Oncology Virtual Symposium being held April 3-5, 2023, in a virtual format.

The Cantor Healthcare Research team will be hosting a series of insightful fireside chats, panel presentations, and 1x1 meetings during the symposium. Aptose's Chief Medical Officer, Rafael Bejar, M.D., Ph.D., will participate in a panel, " Targeted Therapies in AML ."

Cantor's The Future of Oncology Virtual Symposium

Panel Title: Targeted Therapies in AML
Date: Wednesday, April 5, 2023
Time: 12:00 – 12:45 PM Eastern Time
Aptose Speaker : Rafael Bejar, M.D., Ph.D., Senior Vice President and Chief Medical Officer

About Aptose

Aptose Biosciences is a clinical-stage biotechnology company committed to developing precision medicines addressing unmet medical needs in oncology, with an initial focus on hematology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities. The Company has two clinical-stage oral kinase inhibitors under development for hematologic malignancies: tuspetinib (HM43239), an oral, myeloid kinase inhibitor being studied as monotherapy and in combination therapy in the APTIVATE international Phase 1/2 expansion trial in patients with relapsed or refractory acute myeloid leukemia (AML); and luxeptinib (CG-806), an oral, dual lymphoid and myeloid kinase inhibitor in Phase 1 a/b stage development for the treatment of patients with relapsed or refractory hematologic malignancies. For more information, please visit www.aptose.com .

For further information, please contact:
Aptose Biosciences Inc. LifeSci Advisors, LLC
Susan Pietropaolo Dan Ferry, Managing Director
Investor Relations 617-535-7746
201-923-2049 Daniel@LifeSciAdvisors.com
spietropaolo@aptose.com



Primary Logo

News Provided by GlobeNewswire via QuoteMedia

APS:CA,APTO
The Conversation (0)
Cizzle Brands Launching Spoken Nutrition as its Latest Performance-Driven Brand for Athletes

Cizzle Brands Launching Spoken Nutrition as its Latest Performance-Driven Brand for Athletes

Spoken Nutrition™ is a premium brand of athlete-grade nutraceuticals that carry the prestigious NSF Certified for Sport® qualification, making Spoken products eligible for use by athletes in several major-league and minor-league organizations, as well as the NCAA. With purchase orders secured from many professional sports teams, including multiple MLB teams for use during Spring Training leading into the 2025 regular baseball season, the launch of Spoken Nutrition™ cements Cizzle Brands Corporation as a global leader in sports nutrition.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Cizzle Brands Launching Spoken Nutrition as its Latest Performance-Driven Brand for Athletes

Cizzle Brands Launching Spoken Nutrition as its Latest Performance-Driven Brand for Athletes

Spoken Nutrition™ is a premium brand of athlete-grade nutraceuticals that carry the prestigious NSF Certified for Sport® qualification, making Spoken products eligible for use by athletes in several major-league and minor-league organizations, as well as the NCAA. With purchase orders secured from many professional sports teams, including multiple MLB teams for use during Spring Training leading into the 2025 regular baseball season, the launch of Spoken Nutrition™ cements Cizzle Brands Corporation as a global leader in sports nutrition.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
CWENCH Hydration Gains Distribution in Metro Supermarkets Across Ontario

CWENCH Hydration Gains Distribution in Metro Supermarkets Across Ontario

With the debut of CWENCH Hydration™ in its first major Canadian grocer, Cizzle Brands anticipates that it will be able to further penetrate the mainstream consumer market alongside the specialty athletic and fitness-related markets. Starting this month, CWENCH Hydration™ mix packets will be offered in the pharmacy section of 47 Metro supermarkets across the province of Ontario.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
CWENCH Hydration Gains Distribution in Metro Supermarkets Across Ontario

CWENCH Hydration Gains Distribution in Metro Supermarkets Across Ontario

With the debut of CWENCH Hydration™ in its first major Canadian grocer, Cizzle Brands anticipates that it will be able to further penetrate the mainstream consumer market alongside the specialty athletic and fitness-related markets. Starting this month, CWENCH Hydration™ mix packets will be offered in the pharmacy section of 47 Metro supermarkets across the province of Ontario.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

Ă—